HemaSphere (Jun 2022)
P944: A PHASE I STUDY OF C-CAR088, A NOVEL HUMANIZED ANTI-BCMA CAR T CELL THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
- X. Qu,
- G. An,
- W. Sui,
- T. Wang,
- X. Zhang,
- J. Yang,
- Y. Zhang,
- L. Zhang,
- D. Zhu,
- J. Huang,
- S. Zhu,
- X. Yao,
- J. Li,
- C. Zheng,
- S. Chen,
- K. Zhu,
- Y. Wei,
- X. Lv,
- L. Lan,
- Y. Yao,
- D. Zhou,
- P. Lu,
- L. Qiu,
- J. Li
Affiliations
- X. Qu
- 1 Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing
- G. An
- 2 Department of Hematology, Institute of Hematology and Blood Diseases Hospital, Tianjin
- W. Sui
- 2 Department of Hematology, Institute of Hematology and Blood Diseases Hospital, Tianjin
- T. Wang
- 2 Department of Hematology, Institute of Hematology and Blood Diseases Hospital, Tianjin
- X. Zhang
- 3 Department of Hematology, Hebei Yanda Lu Daopei Hospital, Langfang
- J. Yang
- 3 Department of Hematology, Hebei Yanda Lu Daopei Hospital, Langfang
- Y. Zhang
- 4 Department of Hematology, Peking Union Medical College Hospital, Beijing
- L. Zhang
- 4 Department of Hematology, Peking Union Medical College Hospital, Beijing
- D. Zhu
- 5 Cellular Biomedicine Group Inc, Shanghai
- J. Huang
- 5 Cellular Biomedicine Group Inc, Shanghai
- S. Zhu
- 5 Cellular Biomedicine Group Inc, Shanghai
- X. Yao
- 5 Cellular Biomedicine Group Inc, Shanghai
- J. Li
- 5 Cellular Biomedicine Group Inc, Shanghai
- C. Zheng
- 5 Cellular Biomedicine Group Inc, Shanghai
- S. Chen
- 5 Cellular Biomedicine Group Inc, Shanghai
- K. Zhu
- 6 University of Maryland School of Medicine, Maryland, China
- Y. Wei
- 5 Cellular Biomedicine Group Inc, Shanghai
- X. Lv
- 5 Cellular Biomedicine Group Inc, Shanghai
- L. Lan
- 5 Cellular Biomedicine Group Inc, Shanghai
- Y. Yao
- 5 Cellular Biomedicine Group Inc, Shanghai
- D. Zhou
- 4 Department of Hematology, Peking Union Medical College Hospital, Beijing
- P. Lu
- 3 Department of Hematology, Hebei Yanda Lu Daopei Hospital, Langfang
- L. Qiu
- 2 Department of Hematology, Institute of Hematology and Blood Diseases Hospital, Tianjin
- J. Li
- 1 Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing
- DOI
- https://doi.org/10.1097/01.HS9.0000846644.36411.51
- Journal volume & issue
-
Vol. 6
pp. 834 – 835
Abstract
No abstracts available.